FINWIRES · TerminalLIVE
FINWIRES

Yokohama Rubber Unit to Sell Israel Plant Assets for 30 Billion Yen Gain

-- The Yokohama Rubber's (TYO:5101) subsidiary will transfer fixed assets tied to an idle off-highway tire plant in Israel, with the move expected to generate about 30 billion yen in gains, according to a Thursday filing on the Tokyo Stock Exchange.

Alliance Tire Company, the group's consolidated unit, approved the sale of land and buildings linked to the Hadera plant, which ceased operations at the end of December 2024.

The transaction aligns with the company's medium-term plan to optimize its global production network and free up capital for growth investments.

The asset transfer is scheduled for completion on April 16, with the gain to be recorded as other income in the second quarter of the fiscal year ending December 2026.

Related Articles

Asia

Beijing Enlight Media Q1 Profit Falls 99%; Shares Down 8%

Beijing Enlight Media Co (SHE:300251) posted first-quarter attributable net profit of 23.3 million yuan, down 99% from 2.02 billion yuan the previous year.Earnings per share went down to 0.01 yuan from 0.69 yuan, according to a Wednesday filing with the Shenzhen bourse.Operating revenue fell 94% year over year to 190.6 million yuan from 2.97 billion yuan.Shares of the media company were down 8% in recent trade.

$SHE:300251
Asia

Enlight Media 2025 Profit Jumps 473%; Shares Fall 7%

Beijing Enlight Media (SHE:300251) posted 2025 attributable net profit of 1.67 billion yuan, up 473% from 292.0 million yuan the previous year.Earnings per share went up to 0.57 yuan from 0.10 yuan, according to a Wednesday filing with the Shenzhen bourse.Operating revenue jumped 155% year over year to 4.04 billion yuan from 1.59 billion yuan.Shares of the media company were down 7% in recent trade.

$SHE:300251
Asia

CR Double-Crane Pharma Gets Nod to Name Unit as Marketer of Endometriosis Drug

China Resources Double-Crane Pharmaceutical (SHA:600062) received approval from the National Medical Products Administration to change the marketing authorization holder of dienogest tablets, according to a Shanghai bourse filing on Wednesday.Under the approved supplementary application, the pharmaceutical company's subsidiary, CR Zizhu Pharmaceutical, becomes the marketing authorization holder, as well as the manufacturer of the endometriosis drug.

$SHA:600062